Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-13T06:56:46.467Z Has data issue: false hasContentIssue false

Chapter 51 - Hyperviscosity and Strokes

from Section 6 - Systemic Disorders That Also Involve the Cerebrovascular System

Published online by Cambridge University Press:  15 June 2018

By
John F. Dashe
Edited by
Louis Caplan  and
José Biller
Louis Caplan
Affiliation:
Beth Israel-Deaconess Medical Center, Boston
José Biller
Affiliation:
Loyola University Stritch School of Medicine, Chicago
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Uncommon Causes of Stroke , pp. 408 - 417
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, B. D. et al., 2010. Myeloproliferative disorders and the hyperviscosity syndrome. Hematology/Oncology Clinics of North America, 24, 585–602. Available at: www.ncbi.nlm.nih.gov/pubmed/20488356 [Accessed December 15, 2015].CrossRefGoogle ScholarPubMed
Alexandrescu, D. T. et al., 2005. Strokes after intravenous gamma globulin: Thrombotic phenomenon in patients with risk factors or just coincidence? American Journal of Hematology, 78, 216–20. Available at: www.ncbi.nlm.nih.gov/pubmed/15726606 [Accessed November 19, 2015].CrossRefGoogle ScholarPubMed
Allport, L. E. et al., 2005. Elevated hematocrit is associated with reduced reperfusion and tissue survival in acute stroke. Neurology, 65, 1382–7. Available at: www.ncbi.nlm.nih.gov/pubmed/16275824 [Accessed December 15, 2015].Google Scholar
Anon, 1975. Editorial: Haemorheology, blood-flow and venous thrombosis. Lancet, 2, 113–4. Available at: www.ncbi.nlm.nih.gov/pubmed/49700 [Accessed November 22, 2015].Google Scholar
Artoni, A., Bucciarelli, P., & Martinelli, I., 2014. Cerebral thrombosis and myeloproliferative neoplasms. Current Neurology and Neuroscience Reports, 14, 496. Available at: www.ncbi.nlm.nih.gov/pubmed/25217248 [Accessed December 6, 2015].Google Scholar
Baker, I. A. et al., 2002. Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: Evidence from the Caerphilly and Speedwell cohort. Thrombosis and Haemostasis, 87, 421–5. Available at: www.ncbi.nlm.nih.gov/pubmed/11916073 [Accessed November 15, 2015].Google Scholar
Barabas, A. P., Offen, D. N., & Meinhard, E. A., 1973. The arterial complications of polycythaemia vera. British Journal of Surgery, 60, 183–7. Available at: www.ncbi.nlm.nih.gov/pubmed/4693567 [Accessed November 20, 2015].Google Scholar
Berk, P. D. et al., 1986. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Seminars in Hematology, 23, 132–43. Available at: www.ncbi.nlm.nih.gov/pubmed/3704665 [Accessed November 20, 2015].Google Scholar
Billakota, S. & El Husseini, N., 2014. Pearls & oysters: Polycythemia vera presenting with ischemic strokes in multiple arterial territories. Neurology, 82, e168–70. Available at: www.ncbi.nlm.nih.gov/pubmed/24843039 [Accessed December 15, 2015].Google Scholar
Boulanger, E. et al., 2006. Polyclonal IgG4 hypergammaglobulinemia associated with plasmacytic lymphadenopathy, anemia and nephropathy. Annals of Hematology, 85, 833–40. Available at: www.ncbi.nlm.nih.gov/pubmed/16871390 [Accessed December 15, 2015].Google Scholar
Bunn, H. F., 1997. Pathogenesis and treatment of sickle cell disease. New England Journal of Medicine, 337, 762–9. Available at: www.ncbi.nlm.nih.gov/pubmed/9287233 [Accessed November 20, 2015].CrossRefGoogle ScholarPubMed
Byrne, N.P. et al., 2002. Neuropathologic findings in a Guillain–Barré patient with strokes after IVIg therapy. Neurology, 59, 458–61. Available at: www.ncbi.nlm.nih.gov/pubmed/12177388 [Accessed November 20, 2015].Google Scholar
Caplan, L.R., 1995. Binswanger’s disease: Revisited. Neurology, 45, 626–33.Google Scholar
Caress, J. B. et al., 2003. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology, 60, 1822–4. Available at: www.ncbi.nlm.nih.gov/pubmed/12796539 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Caress, J. B. et al., 2009. Case–control study of thromboembolic events associated with IV immunoglobulin. Journal of Neurology, 256, 339–42. Available at: www.ncbi.nlm.nih.gov/pubmed/19253011 [Accessed December 7, 2015].CrossRefGoogle ScholarPubMed
Chang, T. et al., 2014. Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: A case report. Journal of Medical Case Reports, 8, 100. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4007143&tool=pmcentrez&rendertype=abstract [Accessed December 15, 2015].Google Scholar
Chang, T. S. & Jensen, M. B., 2014. Haemodilution for acute ischaemic stroke. The Cochrane Database of Systematic Reviews, 8, CD000103. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4181849&tool=pmcentrez&rendertype=abstract [Accessed November 25, 2015].Google Scholar
Chen, L. Y. et al., 2015. Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions. Clinical Case Reports, 3, 217–26.Google Scholar
Chien, S., Usami, S., & Bertles, J. F., 1970. Abnormal rheology of oxygenated blood in sickle cell anemia. Journal of Clinical Investigation, 49, 623–34. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=322516&tool=pmcentrez&rendertype=abstract [Accessed October 20, 2015].Google Scholar
Choi, W.-J. et al., 2012. Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura. Journal of Stroke and Cerebrovascular Diseases, 21, e9–11. Available at: www.ncbi.nlm.nih.gov/pubmed/22749629 [Accessed December 15, 2015].Google Scholar
Connes, P., Verlhac, S., & Bernaudin, F., 2013. Advances in understanding the pathogenesis of cerebrovascular vasculopathy in sickle cell anaemia. British Journal of Haematology, 161, 484–98. Available at: www.ncbi.nlm.nih.gov/pubmed/23496688 [Accessed December 15, 2015].CrossRefGoogle ScholarPubMed
Coull, B. M. et al., 1991. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke, 22, 162–8. Available at: www.ncbi.nlm.nih.gov/pubmed/2003279 [Accessed November 22, 2015].Google Scholar
Cowan, A. Q., Cho, D. J., & Rosenson, R. S., 2012. Importance of blood rheology in the pathophysiology of atherothrombosis. Cardiovascular Drugs and Therapy, 26, 339–48. Available at: www.ncbi.nlm.nih.gov/pubmed/22821616 [Accessed December 6, 2015].Google Scholar
Danesh, J. et al., 2005. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA, 294, 1799–809. Available at: www.ncbi.nlm.nih.gov/pubmed/16219884 [Accessed November 22, 2015].Google Scholar
Davalos, D. & Akassoglou, K., 2012. Fibrinogen as a key regulator of inflammation in disease. Seminars in Immunopathology, 34, 43–62. Available at: www.ncbi.nlm.nih.gov/pubmed/22037947 [Accessed November 13, 2015].Google Scholar
Dintenfass, L., 1966. A preliminary outline of the blood high viscosity syndromes. Archives of Internal Medicine, 118, 427–35. Available at: www.ncbi.nlm.nih.gov/pubmed/5332028 [Accessed November 22, 2015].Google Scholar
Dintenfass, L., 1968. Internal viscosity of the red cell and a blood viscosity equation. Nature, 219, 956–8. Available at: www.ncbi.nlm.nih.gov/pubmed/5673017 [Accessed November 19, 2015].Google Scholar
Dormandy, J. A., Yates, C. J., & Berent, G. A., 1981. Clinical relevance of blood viscosity and red cell deformability including newer therapeutic aspects. Angiology, 32, 236–42. Available at: www.ncbi.nlm.nih.gov/pubmed/7224233 [Accessed November 22, 2015].Google Scholar
Emerson, G. G., Herndon, C. N., & Sreih, A. G., 2002. Thrombotic complications after intravenous immunoglobulin therapy in two patients. Pharmacotherapy, 22, 1638–41. Available at: www.ncbi.nlm.nih.gov/pubmed/12495174 [Accessed November 22, 2015].Google Scholar
Ernst, E. et al., 1991. Impaired blood rheology: A risk factor after stroke? Journal of Internal Medicine, 229, 457–62. Available at: www.ncbi.nlm.nih.gov/pubmed/2040872 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Ernst, E., 1995. Haemorheological consequences of chronic cigarette smoking. Journal of Cardiovascular Risk, 2, 435–9. Available at: www.ncbi.nlm.nih.gov/pubmed/8749271 [Accessed November 22, 2015].Google Scholar
Fahey, J. L., Barth, W. F., & Solomon, A., 1965. Serum hypervicosity syndrome. JAMA, 192, 464–7. Available at: www.ncbi.nlm.nih.gov/pubmed/14284847 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Fahraeus, R. & Lindqvist, T., 1931. Viscosity of blood in narrow capillary tubes. American Journal of Physiology, 96, 562–8. Available at: www.ncbi.nlm.nih.gov/pubmed/2040872 [Accessed November 22, 2015].Google Scholar
Fisher, M. & Meiselman, H. J., 1991. Hemorheological factors in cerebral ischemia. Stroke, 22, 1164–9. Available at: www.ncbi.nlm.nih.gov/pubmed/1833861 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Forconi, S. & Gori, T., 2013. Endothelium and hemorheology. Clinical Hemorheology and Microcirculation, 53, 3–10. Available at: www.ncbi.nlm.nih.gov/pubmed/22951621 [Accessed December 6, 2015].Google Scholar
Gaehtgens, P. & Marx, P., 1987. Hemorheological aspects of the pathophysiology of cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 7, 259–65. Available at: www.ncbi.nlm.nih.gov/pubmed/3294863 [Accessed November 22, 2015].Google Scholar
Gori, T. et al., 2015. The distribution of whole blood viscosity, its determinants and relationship with arterial blood pressure in the community: Cross-sectional analysis from the Gutenberg Health Study. Therapeutic Advances in Cardiovascular Disease, 9, 354–65. Available at: www.ncbi.nlm.nih.gov/pubmed/26082340 [Accessed December 11, 2015].Google Scholar
Grotemeyer, K. C. et al., 2014. Association of elevated plasma viscosity with small vessel occlusion in ischemic cerebral disease. Thrombosis Research, 133, 96–100. Available at: www.ncbi.nlm.nih.gov/pubmed/24238841 [Accessed December 6, 2015].Google Scholar
Grotta, J. C. et al., 1986. Red blood cell disorders and stroke. Stroke, 17, 811–7. Available at: www.ncbi.nlm.nih.gov/pubmed/3532433 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Hayashi, T. et al., 2015. Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia: A case report. Child’s Nervous System, 31, 991–6. Available at: www.ncbi.nlm.nih.gov/pubmed/25663502 [Accessed November 14, 2015].Google Scholar
Hernández-Gilsoul, T. et al., 2013. Pulmonary hypertension secondary to hyperviscosity in a patient with rheumatoid arthritis and acquired von Willebrand disease: A case report. Journal of Medical Case Reports, 7, 232. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4015717&tool=pmcentrez&rendertype=abstract [Accessed December 15, 2015].Google Scholar
van Hilten, J. J. et al., 1989. Cerebral infarction in hereditary spherocytosis. Stroke, 20, 1755–6. Available at: www.ncbi.nlm.nih.gov/pubmed/2595739 [Accessed November 22, 2015].Google Scholar
Jeffries, B. F., Lipper, M. H., & Kishore, P. R., 1980. Major intracerebral arterial involvement in sickle cell disease. Surgical Neurology, 14, 291–5. Available at: www.ncbi.nlm.nih.gov/pubmed/7434197 [Accessed November 22, 2015].Google Scholar
Juhan, I. et al., 1982. Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet, 1, 535–7. Available at: www.ncbi.nlm.nih.gov/pubmed/6120392 [Accessed November 22, 2015].Google ScholarPubMed
Kannel, W. B. et al., 1972. Hemoglobin and the risk of cerebral infarction: The Framingham Study. Stroke, 3, 409–20. Available at: www.ncbi.nlm.nih.gov/pubmed/4261794 [Accessed November 22, 2015].Google Scholar
Kaptoge, S. et al., 2012. C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine, 367, 1310–20. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3714101&tool=pmcentrez&rendertype=abstract [Accessed December 14, 2015].Google Scholar
Kassim, A. A. & DeBaun, M. R., 2013. Sickle cell disease, vasculopathy, and therapeutics. Annual Review of Medicine, 64, 451–66. Available at: www.ncbi.nlm.nih.gov/pubmed/23190149 [Accessed December 7, 2015].Google Scholar
Kato, G. J. et al., 2009. Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. American Journal of Hematology, 84, 618–25. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3209715&tool=pmcentrez&rendertype=abstract [Accessed November 12, 2015].Google Scholar
Katritsis, D. et al., 2007. Wall shear stress: Theoretical considerations and methods of measurement. Progress in Cardiovascular Diseases, 49, 307–29. Available at: www.ncbi.nlm.nih.gov/pubmed/17329179 [Accessed October 4, 2015].CrossRefGoogle ScholarPubMed
Kawamoto, A. et al., 1991. Factors associated with silent multiple lacunar lesions on magnetic resonance imaging in asymptomatic elderly hypertensive patients. Clinical and Experimental Pharmacology & Physiology, 18, 605–10. Available at: www.ncbi.nlm.nih.gov/pubmed/1835681 [Accessed November 22, 2015].Google Scholar
Khan, U. A., Shanholtz, C. B., & McCurdy, M. T., 2014. Oncologic mechanical emergencies. Emergency Medicine Clinics of North America, 32, 495–508. Available at: www.ncbi.nlm.nih.gov/pubmed/25060246 [Accessed December 6, 2015].Google Scholar
Koenig, W. & Ernst, E., 1992. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis, 94, 93–107. Available at: www.ncbi.nlm.nih.gov/pubmed/1632876 [Accessed November 22, 2015].Google Scholar
Kossorotoff, M. et al., 2015. Cerebral haemorrhagic risk in children with sickle-cell disease. Developmental Medicine and Child Neurology, 57, 187–93. Available at: www.ncbi.nlm.nih.gov/pubmed/25174812 [Accessed December 16, 2015].CrossRefGoogle ScholarPubMed
Kwaan, H. C., 2010. Role of plasma proteins in whole blood viscosity: A brief clinical review. Clinical Hemorheology and Microcirculation, 44, 167–76. Available at: www.ncbi.nlm.nih.gov/pubmed/20364062 [Accessed November 22, 2015].Google Scholar
Kwaan, H.C., 2013. Hyperviscosity in plasma cell dyscrasias. Clinical Hemorheology and Microcirculation, 55, 75–83. Available at: www.ncbi.nlm.nih.gov/pubmed/23455837 [Accessed December 11, 2015].Google Scholar
Landolfi, R., Cipriani, M. C., & Novarese, L., 2006. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: Pathogenetic mechanisms and prevention. Best Practice & Research. Clinical Haematology, 19, 617–33. Available at: www.ncbi.nlm.nih.gov/pubmed/16781491 [Accessed December 15, 2015].Google Scholar
Leonhardt, H., Arntz, H. R., & Klemens, U. H., 1977. Studies of plasma viscosity in primary hyperlipoproteinaemia. Atherosclerosis, 28, 29–40. Available at: www.ncbi.nlm.nih.gov/pubmed/199202 [Accessed November 22, 2015].Google Scholar
Lorenzana, A. et al., 2014. Cerebral infarctions after intravenous immunoglobulin therapy for ITP in a child. Pediatric Neurology, 50, 188–91. Available at: www.ncbi.nlm.nih.gov/pubmed/24262342 [Accessed December 15, 2015].Google Scholar
Lowe, G. D. et al., 1982. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet, 1, 472–5. Available at: www.ncbi.nlm.nih.gov/pubmed/6121140 [Accessed November 22, 2015].Google Scholar
Lowe, G. D., 1987. Blood rheology in general medicine and surgery. Baillière’s Clinical Haematology, 1, 827–61. Available at: www.ncbi.nlm.nih.gov/pubmed/3327567 [Accessed November 22, 2015].Google Scholar
Lowe, G. D., 1995. Fibrinogen and cardiovascular disease: Historical introduction. European Heart Journal, 16 Suppl A, 2–5. Available at: www.ncbi.nlm.nih.gov/pubmed/7796825 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Lowe, G. D. et al., 1997. Blood viscosity and risk of cardiovascular events: The Edinburgh Artery Study. British Journal of Haematology, 96, 168–73. Available at: www.ncbi.nlm.nih.gov/pubmed/9012704 [Accessed November 22, 2015].Google Scholar
Lowe, G. D., 1998. Etiopathogenesis of cardiovascular disease: Hemostasis, thrombosis, and vascular medicine. Annals of Periodontology, 3, 121–6. Available at: www.ncbi.nlm.nih.gov/pubmed/9722696 [Accessed November 22, 2015].Google Scholar
Lowe, G. D. O., 2005. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. Journal of Thrombosis and Haemostasis, 3, 1618–27. Available at: www.ncbi.nlm.nih.gov/pubmed/16102027 [Accessed November 22, 2015].Google Scholar
Lowe, G. D. O., 2006. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. British Journal of Haematology, 133, 232–50. Available at: www.ncbi.nlm.nih.gov/pubmed/16643425 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Lowe, G. & Rumley, A., 2014. The relevance of coagulation in cardiovascular disease: What do the biomarkers tell us? Thrombosis and Haemostasis, 112, 860–7. Available at: www.ncbi.nlm.nih.gov/pubmed/25231258 [Accessed December 14, 2015].Google Scholar
Malek, A. M., Alper, S. L., & Izumo, S., 1999. Hemodynamic shear stress and its role in atherosclerosis. JAMA, 282, 2035–42. Available at: www.ncbi.nlm.nih.gov/pubmed/10591386 [Accessed November 21, 2015].Google Scholar
Marchioli, R. et al., 2013. Cardiovascular events and intensity of treatment in polycythemia vera. The New England Journal of Medicine, 368, 22–33. Available at: www.ncbi.nlm.nih.gov/pubmed/23216616 [Accessed November 10, 2015].Google Scholar
McMillan, D. E., 1985. Hemorheologic changes in diabetes and their role in increased atherogenesis. Hormone and Metabolic Research. Supplement Series, 15, 73–9. Available at: www.ncbi.nlm.nih.gov/pubmed/3865884 [Accessed November 22, 2015].Google Scholar
McMillan, D. E., 1989. Increased levels of acute-phase serum proteins in diabetes. Metabolism: Clinical and Experimental, 38, 1042–6. Available at: www.ncbi.nlm.nih.gov/pubmed/2478861 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
McMillan, D. E., 1997. Development of vascular complications in diabetes. Vascular Medicine, 2, 132–42. Available at: www.ncbi.nlm.nih.gov/pubmed/9546955 [Accessed November 22, 2015].Google Scholar
Melamed, E. et al., 1976. Aseptic cavernous sinus thrombosis after internal carotid arterial occlusion in polycythaemia vera. Journal of Neurology, Neurosurgery, and Psychiatry, 39, 320–4. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=492279&tool=pmcentrez&rendertype=abstract [Accessed November 22, 2015].Google Scholar
Noda, S. et al., 2011. Hyperviscosity syndrome associated with systemic plasmacytosis. Clinical and Experimental Dermatology, 36, 273–6. Available at: www.ncbi.nlm.nih.gov/pubmed/20738318 [Accessed December 15, 2015].Google Scholar
Ohene-Frempong, K. et al., 1998. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91, 288–94. Available at: www.ncbi.nlm.nih.gov/pubmed/9414296 [Accessed November 22, 2015].Google Scholar
Ott, E. O., Lechner, H., & Aranibar, A., 1974. High blood viscosity syndrome in cerebral infarction. Stroke, 5, 330–3. Available at: www.ncbi.nlm.nih.gov/pubmed/4836535 [Accessed November 22, 2015].Google Scholar
Paniagua, O. A., Bryant, M. B., & Panza, J. A., 2001. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: Diminished activity in hypertensive and hypercholesterolemic patients. Circulation, 103, 1752–8. Available at: www.ncbi.nlm.nih.gov/pubmed/11282906 [Accessed December 11, 2015].Google Scholar
Paraskevas, K. I. et al., 2008. The role of fibrinogen and fibrinolysis in peripheral arterial disease. Thrombosis Research, 122, 1–12. Available at: www.ncbi.nlm.nih.gov/pubmed/17669476 [Accessed December 6, 2015].Google Scholar
Paszkowiak, J. J. & Dardik, A., 2003. Arterial wall shear stress: Observations from the bench to the bedside. Vascular and Endovascular Surgery, 37, 47–57. Available at: www.ncbi.nlm.nih.gov/pubmed/12577139 [Accessed November 22, 2015].Google Scholar
Paul, B., 2002. Polyclonal hypergammaglobulinaemia with hyperviscosity syndrome. British Journal of Haematology, 118, 922–3. Available at: www.ncbi.nlm.nih.gov/pubmed/12181068 [Accessed December 15, 2015].Google Scholar
Pavlakis, S. G. et al., 1988. Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates. Annals of Neurology, 23, 125–30. Available at: www.ncbi.nlm.nih.gov/pubmed/3377435 [Accessed November 22, 2015].Google Scholar
Pearce, J. M., Chandrasekera, C. P., & Ladusans, E. J., 1983. Lacunar infarcts in polycythaemia with raised packed cell volumes. British Medical Journal, 287, 935–6. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1549171&tool=pmcentrez&rendertype=abstract [Accessed November 22, 2015].Google Scholar
Pearson, T.C. & Wetherley-Mein, G., 1978. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia. Lancet, 2, 1219–22. Available at: www.ncbi.nlm.nih.gov/pubmed/82733 [Accessed November 22, 2015].Google Scholar
Preul, M. C. et al., 1998. Intracranial aneurysms and sickle cell anemia: Multiplicity and propensity for the vertebrobasilar territory. Neurosurgery, 42, 971–7. Available at: www.ncbi.nlm.nih.gov/pubmed/9588540 [Accessed December 16, 2015].Google Scholar
Rampling, M. W., 2003. Hyperviscosity as a complication in a variety of disorders. Seminars in Thrombosis and Hemostasis, 29, 459–65. Available at: www.ncbi.nlm.nih.gov/pubmed/14631545 [Accessed November 22, 2015].Google Scholar
Reinhart, W. H. & Berchtold, P. E., 1992. Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet, 339, 662–4. Available at: www.ncbi.nlm.nih.gov/pubmed/1347348 [Accessed November 22, 2015].Google Scholar
Rezai, K. A. et al., 2002. Rheumatoid hyperviscosity syndrome: Reversibility of microvascular abnormalities after treatment. American Journal of Ophthalmology, 134, 130–2. Available at: www.ncbi.nlm.nih.gov/pubmed/12095825 [Accessed December 15, 2015].Google Scholar
Rosenson, R. S. & Lowe, G. D., 1998. Effects of lipids and lipoproteins on thrombosis and rheology. Atherosclerosis, 140, 271–80. Available at: www.ncbi.nlm.nih.gov/pubmed/9862270 [Accessed November 22, 2015].Google Scholar
Rothman, S. M., Fulling, K. H., & Nelson, J. S., 1986. Sickle cell anemia and central nervous system infarction: A neuropathological study. Annals of Neurology, 20, 684–90. Available at: www.ncbi.nlm.nih.gov/pubmed/3813497 [Accessed November 22, 2015].Google Scholar
Sakuta, S., 1981. Blood filtrability in cerebrovascular disorders, with special reference to erythrocyte deformability and ATP content. Stroke, 12, 824–8. Available at: www.ncbi.nlm.nih.gov/pubmed/7303073 [Accessed November 22, 2015].Google Scholar
Schneider, R. et al., 1985. The haemorheological features of lacunar strokes. Journal of Neurology, 232, 357–62. Available at: www.ncbi.nlm.nih.gov/pubmed/4078601 [Accessed November 22, 2015].Google Scholar
Schneider, R. et al., 1987. The role of plasma hyperviscosity in subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Journal of Neurology, 234, 67–73. Available at: www.ncbi.nlm.nih.gov/pubmed/3559641 [Accessed November 22, 2015].Google Scholar
Seplowitz, A. H., Chien, S., & Smith, F. R., 1981. Effects of lipoproteins on plasma viscosity. Atherosclerosis, 38, 89–95. Available at: www.ncbi.nlm.nih.gov/pubmed/7470209 [Accessed November 22, 2015].Google Scholar
Silverstein, A., Gilbert, H., & Wasserman, L. R., 1962. Neurologic complications of polycythemia. Annals of Internal Medicine, 57, 909–16. Available at: www.ncbi.nlm.nih.gov/pubmed/13992952 [Accessed November 22, 2015].Google Scholar
Sloop, G. D., 1996. A unifying theory of atherogenesis. Medical Hypotheses, 47, 321–5. Available at: www.ncbi.nlm.nih.gov/pubmed/8910882 [Accessed November 22, 2015].CrossRefGoogle ScholarPubMed
Sloop, G. D., Weidman, J. J., & St Cyr, J. A., 2015. The systemic vascular resistance response: A cardiovascular response modulating blood viscosity with implications for primary hypertension and certain anemias. Therapeutic Advances in Cardiovascular Disease, 9, 403–11. Available at: www.ncbi.nlm.nih.gov/pubmed/26116626 [Accessed December 6, 2015].Google Scholar
Somer, T. & Meiselman, H. J., 1993. Disorders of blood viscosity. Annals of Medicine, 25, 31–9. Available at: www.ncbi.nlm.nih.gov/pubmed/8435185 [Accessed November 22, 2015].Google Scholar
Squizzato, A. et al., 2013. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. The Cochrane Database of Systematic Reviews, 4, CD006503. Available at: www.ncbi.nlm.nih.gov/pubmed/23633335 [Accessed December 16, 2015].Google Scholar
Stetefeld, H. R. et al., 2014. Posterior reversible encephalopathy syndrome and stroke after intravenous immunoglobulin treatment in Miller–Fisher syndrome/Bickerstaff brain stem encephalitis overlap syndrome. Journal of Stroke and Cerebrovascular Diseases, 23, e423–5. Available at: www.ncbi.nlm.nih.gov/pubmed/25149206 [Accessed December 15, 2015].CrossRefGoogle ScholarPubMed
Stiehm, E. R., 2013. Adverse effects of human immunoglobulin therapy. Transfusion Medicine Reviews, 27, 171–8. Available at: www.ncbi.nlm.nih.gov/pubmed/23835249 [Accessed November 20, 2015].Google Scholar
Stockman, J. A. et al., 1972. Occlusion of large cerebral vessels in sickle-cell anemia. New England Journal of Medicine, 287, 846–9. Available at: www.ncbi.nlm.nih.gov/pubmed/5071963 [Accessed November 22, 2015].Google Scholar
Stone, M. J. & Bogen, S. A., 2012. Evidence-based focused review of management of hyperviscosity syndrome. Blood, 119, 2205–8. Available at: www.ncbi.nlm.nih.gov/pubmed/22147890 [Accessed November 25, 2015].Google Scholar
Stuart, J. et al., 1981. Haematological stress syndrome in atherosclerosis. Journal of Clinical Pathology, 34, 464–7. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=493325&tool=pmcentrez&rendertype=abstract [Accessed November 22, 2015].Google Scholar
Stucki, A. et al., 2001. Endothelial cell activation by myeloblasts: Molecular mechanisms of leukostasis and leukemic cell dissemination. Blood, 97, 2121–9. Available at: www.ncbi.nlm.nih.gov/pubmed/11264180 [Accessed December 15, 2015].Google Scholar
Szapary, L. et al., 2004. Hemorheological disturbances in patients with chronic cerebrovascular diseases. Clinical Hemorheology and Microcirculation, 31, 1–9. Available at: www.ncbi.nlm.nih.gov/pubmed/15272148 [Accessed December 11, 2015].Google Scholar
Tefferi, A., 1999. Pathogenetic mechanisms in chronic myeloproliferative disorders: Polycythemia vera, essential thrombocythemia, agiogenic myeloid metaplasia, and chronic myelogenous leukemia. Seminars in Hematology, 36(1 Suppl 2), 3–8. Available at: www.ncbi.nlm.nih.gov/pubmed/9930550 [Accessed December 15, 2015].Google Scholar
Tefferi, A. et al., 2013. Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study. Leukemia, 27, 1874–81. Available at: www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3768558&tool=pmcentrez&rendertype=abstract [Accessed November 17, 2015].Google Scholar
Thomas, D. J. et al., 1977. Cerebral blood-flow in polycythaemia. Lancet, 2, 161–3. Available at: www.ncbi.nlm.nih.gov/pubmed/69781 [Accessed November 22, 2015].Google Scholar
Thomas, D. J., 1982. Whole blood viscosity and cerebral blood flow. Stroke, 13, 285–7. Available at: www.ncbi.nlm.nih.gov/pubmed/7080118 [Accessed November 19, 2015].Google Scholar
Tohgi, H. et al., 1978. Importance of the hematocrit as a risk factor in cerebral infarction. Stroke, 9, 369–74. Available at: www.ncbi.nlm.nih.gov/pubmed/675749 [Accessed November 22, 2015].Google Scholar
Vucic, S. et al., 2004. Thromboembolic complications of intravenous immunoglobulin treatment. European Neurology, 52, 141–4. Available at: www.ncbi.nlm.nih.gov/pubmed/15479982 [Accessed November 22, 2015].Google Scholar
Wada, Y. et al., 2006. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease. Journal of Pediatrics, 148, 399–400. Available at: www.ncbi.nlm.nih.gov/pubmed/16615977 [Accessed December 15, 2015].Google Scholar
Wang, W. C. & Dwan, K., 2013. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease. The Cochrane Database of Systematic Reviews, 11, CD003146. Available at: www.ncbi.nlm.nih.gov/pubmed/24226646 [Accessed December 16, 2015].Google Scholar
Wells, R. Jr., 1970. Syndromes of hyperviscosity. New England Journal of Medicine, 283, 183–6. Available at: www.ncbi.nlm.nih.gov/pubmed/4987394 [Accessed November 22, 2015].Google Scholar
Wells, R. E., 1964. Rheology of blood in the microvasculature. New England Journal of Medicine, 270, 832–9. Available at: www.ncbi.nlm.nih.gov/pubmed/14108089 [Accessed November 22, 2015].Google Scholar
White, D. A. & Leonard, M. C., 2007. Acute stroke with high-dose intravenous immune globulin. American Journal of Health-System Pharmacy, 64, 1611–4. Available at: www.ncbi.nlm.nih.gov/pubmed/17646563 [Accessed December 6, 2015].Google Scholar
Wong, P.C.W. et al., 2013. IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy. European Journal of Haematology, 90, 250–6. Available at: www.ncbi.nlm.nih.gov/pubmed/23278107 [Accessed December 15, 2015].Google Scholar
Wood, J. H. & Kee, D. B., 1985. Hemorheology of the cerebral circulation in stroke. Stroke, 16, 765–72. Available at: www.ncbi.nlm.nih.gov/pubmed/3901420 [Accessed November 19, 2015].Google Scholar
Wood, K. C., Hsu, L. L., & Gladwin, M. T., 2008. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radical Biology & Medicine, 44, 1506–28. Available at: www.ncbi.nlm.nih.gov/pubmed/18261470 [Accessed December 15, 2015].Google Scholar
Woodward, M. et al., 2005. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke, 36, 2143–7. Available at: www.ncbi.nlm.nih.gov/pubmed/16151030 [Accessed November 22, 2015].Google Scholar
Yazdi, R. & Côté, C., 1986. Watershed infarction in a case of polycythemia vera. Clinical Nuclear Medicine, 11, 665–6. Available at: www.ncbi.nlm.nih.gov/pubmed/3769364 [Accessed November 22, 2015].Google Scholar
Yedgar, S., Koshkaryev, A., & Barshtein, G., 2002. The red blood cell in vascular occlusion. Pathophysiology of Haemostasis and Thrombosis, 32, 263–8. Available at: www.ncbi.nlm.nih.gov/pubmed/13679654 [Accessed December 11, 2015].Google Scholar
Zhang, W. et al., 2006. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia. Clinical and Laboratory Haematology, 28, 177–82. Available at: www.ncbi.nlm.nih.gov/pubmed/16706934 [Accessed December 15, 2015].Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×